³Ô¹ÏÍøÕ¾

Latest neutralizing antibodies News

Brain inflammation may be the reason behind muscle fatigue after infection and injury
Childhood HIV vaccination strategy shows promise in study
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
Insights from patient who cleared hepatitis C could lead to vaccine
Vaccine shows promise against CMV, a virus that causes birth defects
WHO initiative signs new licensing agreements on COVID-19 technologies
COVID boosters show value for those pregnant or trying to conceive
Positive CHMP Opinion Etranacogene Dezaparvovec
CSL’s Novel Gene Therapy HEMGENIX Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living
Experimental vaccines offer long-term protection against severe COVID
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
New Omicron subvariant largely evades neutralizing antibodies
Vaccine Expected to Induce Strong Immune Responses Against 2022 Monkeypox Virus, Research Shows
New generation of corona vaccine shows promising results
Maternal antibodies may protect babies from cytomegalovirus
Novel HIV combination therapies could prevent viral escape and rebound